The PBM Transparency Act will not lower drug prices

Forbes

15 February 2023 - While members of Congress agree on the need to try to rein in the prices of prescription drugs, there is less consensus as to how this might be accomplished. 

Unfortunately, some of the ideas currently being considered would have the unintended consequences of reducing competition in the marketplace, and ultimately raising drug prices even higher.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing